Find your next paid study

Mclean HospitalNCT05665491

~$10 – $750

Actual pay is set by the research site.

Translational Underpinnings of Motivation for Alcohol in Humans

The goal of this translational study is to understand different reasons why people between the ages of 21 and 65 with alcohol use disorder are motivated to sel…

Alcohol Use Disorder

University of California, Los AngelesNCT06494891

Actual pay is set by the research site.

Integrating Complementary Learning Principles in Aphasia Rehabilitation Via Adaptive Modeling (Sub-study 1: Balancing Effortful and Errorless Learning Via Adaptive Naming Deadlines)

Aphasia is a language disorder caused by stroke and other acquired brain injuries that affects over two million people in the United States and which interfere…

AphasiaStroke

University of PittsburghNCT05653440

Actual pay is set by the research site.

Phase 1

A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY OF PF-08052667 AS A SINGLE AGENT AND IN COMBINATION THERAPY IN PARTICIPANTS 18 YEARS OF AGE AND OLDER WITH BLADDER CANCER

The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmett…

Non-muscle Invasive Bladder Cancer

Treatment Resistant Depression

~$150 – $4,500

Actual pay is set by the research site.

PfizerNCT07206225

Observational

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline dep…

~$10 – $1,125

Actual pay is set by the research site.

LivaNovaNCT03887715

Intermittent Explosive Disorder

Inflammatory Challenge in Human Aggression.

The goal of this clinical trial is to explore the differences in behavioral and cytokine response to a low dose infusion of endotoxin (vs. placebo) in individu…

Ohio State UniversityNCT06665074

Actual pay is set by the research site.

Phase 3

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease

The primary objective of this study is to determine the effect of mitapivat versus placebo on the need for transfusions in subjects with SCD.

Sickle Cell Disease

Agios Pharmaceuticals, Inc.NCT07656415

~$50 – $2,100

Actual pay is set by the research site.

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases

Study patients will receive Whole-brain radiation therapy (WBRT) - pulsed reduced dose rate (PRDR) within 14 days of registration. All patients will receive si…

Brain Metastases

Medical College of WisconsinNCT05045950

Actual pay is set by the research site.

Observational

Community-based Exercise to Improve Physical Functioning and Cardiovascular Health Following Revascularization for Peripheral Artery Disease

The primary goal of this clinical trial is to evaluate whether a community-based structured exercise therapy (CB-SET) intervention, which could be accessible a…

Peripheral Artery Disease

University of MinnesotaNCT04252950

~$10 – $750

Actual pay is set by the research site.

Phase 1

Does Ablation (Cryoablation or Histotripsy) Boost Immune Response Improving the Benefits of Pembrolizumab in Patients With Metastatic or Locally Advanced Triple Negative Breast Cancer?

Participants will have a confirmed diagnosis of metastatic breast cancer and will receive pembrolizumab in combination with ablation (cryoablation or histotrip…

Metastatic Breast CancerBreast CancerBreast Cancer Stage IV+5 more

Memorial Sloan Kettering Cancer CenterNCT06246968

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

A Double-blind, Placebo-controlled Phase Ib Study Evaluating the Safety and Toxicity of Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)

CAR-T cell therapy is an emerging treatment modality in relapsed and refractory multiple myeloma (MM). CAR-T therapy in MM relies on directing autologous T-cel…

Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma, Refractory

Washington University School of MedicineNCT07200089

~$150 – $3,000

Actual pay is set by the research site.

Observational

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of…

Brain Disease